Brunei Darussalam
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.013 (0.012–0.013) 3 (2.9–3.2)
Mortality (HIV+TB only) <0.01 (0–<0.01) 0.12 (0–0.9)
Prevalence  (includes HIV+TB) 0.37 (0.14–0.7) 90 (35–169)
Incidence  (includes HIV+TB) 0.28 (0.24–0.32) 68 (59–77)
Incidence (HIV+TB only) <0.01 (0–<0.01) 0.43 (0–2.1)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 119 (52) Relapse 14 (100)
Smear-negative 51 (22) Treatment after failure 0 (0)
Smear-unknown / not done 28 (12) Treatment after default 0 (0)
Extrapulmonary 31 (14) Other 0 (0)
Other 0 (0)      
Total new 229   Total retreatment 14  
           
Other (history unknown) 0        
Total new and relapse 243   Total cases notified 243  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.9 1.5 1.4
Age < 15 0 0 1
Laboratories 2012
Smear (per 100 000 population) 0.2
Culture (per 5 million population) 12.1
Drug susceptibility testing (per 5 million population) 12.1
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 66   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 67  
Retreatment 63  
TB/HIV 2012 Number (%)
TB patients with known HIV status 243 (100)
HIV-positive TB patients 2 (<1)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 2 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 2 (100)
HIV-positive people screened for TB 40  
HIV-positive people provided with IPT 0  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0 (0–2.2) 0 (0–23)
MDR-TB cases among notified pulmonary
TB cases
0 (0–4) 0 (0–3)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 166 (100%) 14 (100%) 180
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-19 Data: www.who.int/tb/data